New York City-based NYU Langone Health has launched a digital pathology program, allowing for pathologists to switch to analyzing high-definition digital images as opposed to physical slides for disease diagnosis.

Norfolk, Va.-based Sentara Healthcare has partnered with Quest Diagnostics to expand access to high-quality and affordable laboratory testing for members of Sentara Health Plans.

As we look ahead to 2025, a number of factors poise the clinical laboratory market for continued transformation. The post-COVID-19 landscape is reshaping the industry, presenting both challenges and opportunities. At Mayo Clinic Laboratories, we are committed to partnering with physicians, laboratory leaders, and hospital administrators in navigating these changes while maintaining an unwavering focus on patient-centered innovation.

Swedish researchers found a blood test can diagnose Alzheimer's disease with a 91% accuracy — about 20% higher than dementia specialists.

More patients are turning to DIY testing to understand and treat their conditions, but physicians worry the tests could lead to unsafe practices, The Washington Post reported June 9.

Intermountain Health's central lab in Murray, Utah, has expanded and nearly doubled in size to help lower testing costs and improve lab services for patients and the system's hospitals in the region. 

The FDA finalized a rule April 29 to treat laboratory-developed tests as medical devices, putting them in the purview of federal oversight. 

Utica, N.Y.-based Masonic Medical Research Institute is proposing to build a 32,000-square-foot laboratory in East Utica, the Utica Observer-Dispatch reported Jan. 11.

Rhode Island Primary Care Physicians Corp., the biggest physician-led healthcare organization in the state of Rhode Island, recently announced a joint venture with Akido Labs, a leader in AI, safety-net and population management programs. 

University of Basel (Switzerland) and University Hospital Basel researchers discovered 35 unknown bacterial pathogens in blood or tissue samples, including seven that caused clinical infections.

A new automation system from Abbott, designed to improve workflows in clinical lab settings, has been granted FDA approval.

The American Hospital Association is urging the FDA not to move forward with a proposed rule to treat laboratory-developed tests as medical devices, saying the move would disrupt innovation and potentially increase hospital costs. 

Standard hospital urine drug analyses do not test for current popular drugs that lead to fatal overdoses, leading to missing diagnoses, according to an opinion piece published Nov. 15 in Scientific American.

New Hyde Park, N.Y.-based Northwell Health has unveiled a three-in-one swab to test for COVID-19, flu and respiratory syncytial virus. 

Hackensack Meridian Health is spinning off its first company based on science from its research institute, the Edison, N.J.-based system said Oct. 4.

Quest Diagnostics was recently granted a breakthrough device designation from the FDA for its adeno-associated virus test. 

The CDC could restructure its lab operations under recent recommendations made by its Laboratory Workgroup.

The CDC plans to overhaul its lab operations after mishaps with its COVID-19 test, KFF Health News reported Aug. 21. 

Three of Orlando (Fla.) Health's laboratories recently received accreditation from the College of American Pathologists.

Quest Diagnostics acquired assets from NewYork-Presbyterian' lab business in an all-cash transaction for $275 million, according to financial documents filed July 27 with the Securities and Exchange Commission.